Tag: Multiple Sclerosis
Risk of Conversion to Multiple Sclerosis Down With Minocycline
Treatment with minocycline reduces conversion to MS over six months after first demyelinating event
Brain Changes in MS May Contribute to Lack of Empathy
Diffuse normal-appearing white matter damage may create disconnection in social brain network
Enhanced Atypical Lymphocytes in Natalizumab-Treated MS
Enhanced fraction of atypical lymphocytes, especially binucleated and plasmacytoid lymphocytes
Pharmacist Program Can Improve IFN-β Adherence in MS
Increase in patient knowledge scores from baseline to end of third visit at three months
Genetic Variant Tied to MS and Systemic Lupus Identified
However, BAFF variant was likely selected over time as an adaptive response to malaria
AAN: Early Research Promising for Immunotherapy in MS
Investigators employ the relationship between MS and Epstein-Barr virus
Circulating Exosomes Have Distinct RNA Profile in MS
Serum exosomal expression of four microRNAs significantly decreased during relapse
AAN: Cannabis-Based Medicine May Help Tough-to-Treat Epilepsy
Cannabidiol appears to lessen drop seizures for some Lennox-Gastaut syndrome patients
C-Section, Maternal Health Impact Odds of Pediatric MS
Possible association for pesticide-related environmental exposures with pediatric-onset MS
FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis
First drug sanctioned in United States for primary progressive multiple sclerosis
